CPHXL2
gene geneOn this page
Summary
CPHXL2 (cytoplasmic polyadenylated homeobox like 2, HGNC:55919) is a protein-coding gene on chromosome 16q23.1, encoding Cytoplasmic polyadenylated homeobox-like protein 2 (A0A1W2PPK0).
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 112268164 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001395862
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55919 |
| Approved symbol | CPHXL2 |
| Name | cytoplasmic polyadenylated homeobox like 2 |
| Location | 16q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000284484 |
| Ensembl biotype | protein_coding |
| Entrez | 112268164 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000640173
RefSeq mRNA: 1 — MANE Select: NM_001395862
NM_001395862
CCDS: CCDS92197
Canonical transcript exons
ENST00000640173 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003806701 | 75660227 | 75661249 |
| ENSE00003809117 | 75676987 | 75677009 |
| ENSE00003810341 | 75669363 | 75669556 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 81.97.
Top tissues by expression
67 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.97 | gold quality |
| calcaneal tendon | UBERON:0003701 | 63.36 | gold quality |
| sural nerve | UBERON:0015488 | 56.61 | silver quality |
| colonic epithelium | UBERON:0000397 | 52.69 | gold quality |
| bone marrow cell | CL:0002092 | 50.03 | gold quality |
| corpus callosum | UBERON:0002336 | 49.71 | silver quality |
| bone marrow | UBERON:0002371 | 45.35 | gold quality |
| urinary bladder | UBERON:0001255 | 44.05 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 43.70 | gold quality |
| blood | UBERON:0000178 | 42.88 | silver quality |
| cortex of kidney | UBERON:0001225 | 42.06 | silver quality |
| tonsil | UBERON:0002372 | 41.51 | gold quality |
| ventricular zone | UBERON:0003053 | 40.99 | gold quality |
| apex of heart | UBERON:0002098 | 39.58 | silver quality |
| muscle tissue | UBERON:0002385 | 38.65 | gold quality |
| adrenal tissue | UBERON:0018303 | 36.75 | gold quality |
| granulocyte | CL:0000094 | 36.54 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 36.41 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.74 | silver quality |
| primary visual cortex | UBERON:0002436 | 35.66 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| muscle of leg | UBERON:0001383 | 35.34 | silver quality |
| descending thoracic aorta | UBERON:0002345 | 35.22 | gold quality |
| left uterine tube | UBERON:0001303 | 34.79 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 34.70 | gold quality |
| monocyte | CL:0000576 | 34.38 | gold quality |
| leukocyte | CL:0000738 | 34.32 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 33.97 | gold quality |
| islet of Langerhans | UBERON:0000006 | 33.89 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.44 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cphx1 | ENSMUSG00000095975 |
| rattus_norvegicus | Cphx1 | ENSRNOG00000025433 |
| drosophila_melanogaster | en | FBGN0000577 |
| drosophila_melanogaster | inv | FBGN0001269 |
| caenorhabditis_elegans | WBGENE00000439 |
Paralogs (3): EN1 (ENSG00000163064), EN2 (ENSG00000164778), CPHXL (ENSG00000283755)
Protein
Protein identifiers
Cytoplasmic polyadenylated homeobox-like protein 2 — A0A1W2PPK0 (reviewed: A0A1W2PPK0)
All UniProt accessions (1): A0A1W2PPK0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001382791* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050720 | Engrailed_Homeobox_TFs | Family |
Pfam: PF00046
UniProt features (5 total): compositionally biased region 2, chain 1, DNA-binding region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1W2PPK0-F1 | 51.33 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 6 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chr16q23, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY, GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (3): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
180 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CPHXL2 | CUX2 | O14529 | 247 |
| CPHXL2 | PLAC9 | Q5JTB6 | 219 |
| CPHXL2 | TMEM254 | Q8TBM7 | 204 |
| CPHXL2 | TIMM10 | P62072 | 184 |
| CPHXL2 | TIMM44 | O43615 | 178 |
| CPHXL2 | OCA2 | Q04671 | 177 |
| CPHXL2 | TIMM13 | P62206 | 167 |
| CPHXL2 | TIMM21 | Q9BVV7 | 166 |
| CPHXL2 | SDHC | Q99643 | 166 |
| CPHXL2 | ALDH4A1 | P30038 | 166 |
| CPHXL2 | NOL9 | Q5SY16 | 166 |
| CPHXL2 | TIMM50 | Q3ZCQ8 | 166 |
| CPHXL2 | SDHD | O14521 | 164 |
| CPHXL2 | DUXB | A0A1W2PPF3 | 163 |
| CPHXL2 | CHCHD4 | Q8N4Q1 | 161 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GVQ3, A0A1W2PPK0, A0A1W2PPM1, A2A9I7, A6NCI8, A6QQS3, A7XCE8, E9PI22, E9PXT9, O15016, O91083, P09414, P0DMB1, P17923, P18804, P20879, P35965, P49750, Q0P670, Q12857, Q1RMX6, Q32LN6, Q32MG2, Q3B8N5, Q3T016, Q3V0A6, Q4JK59, Q5BI31, Q5T035, Q5ZKH6, Q642A3, Q6AXV6, Q6IMN6, Q6P1W5, Q6PEX7, Q6X4T0, Q80YD3, Q86UF4, Q8BII1, Q8C5V0
Diamond homologs: A0A1W2PPK0, A0A1W2PPM1, A1A546, A1YEY5, A1YFI3, A1YG57, A1YGA2, A2T733, A2T777, A2T7P4, A6NFQ7, G5EC89, L8E946, O14813, O15499, O35690, O42250, O42356, O42357, O42477, O70137, O73917, O75360, O95076, O97670, P0DMV5, P26367, P26630, P29454, P41935, P47237, P47238, P53544, P53545, P53546, P54366, P55813, P55864, P56915, P56916
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2647 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:75661241:G:C | F72L | 0.995 |
| 16:75661241:G:T | F72L | 0.995 |
| 16:75661243:A:G | F72L | 0.995 |
| 16:75661242:A:G | F72S | 0.993 |
| 16:75669477:A:C | F31L | 0.993 |
| 16:75669477:A:T | F31L | 0.993 |
| 16:75669479:A:G | F31L | 0.993 |
| 16:75669454:A:G | L39P | 0.989 |
| 16:75661244:C:A | W71C | 0.984 |
| 16:75661244:C:G | W71C | 0.984 |
| 16:75669478:A:G | F31S | 0.984 |
| 16:75661246:A:G | W71R | 0.983 |
| 16:75661246:A:T | W71R | 0.983 |
| 16:75669387:A:C | F61L | 0.983 |
| 16:75669387:A:T | F61L | 0.983 |
| 16:75669389:A:G | F61L | 0.983 |
| 16:75661229:T:A | R76S | 0.978 |
| 16:75661229:T:G | R76S | 0.978 |
| 16:75661242:A:C | F72C | 0.977 |
| 16:75669478:A:C | F31C | 0.977 |
| 16:75669454:A:T | L39H | 0.976 |
| 16:75669397:G:T | A58D | 0.975 |
| 16:75669398:C:G | A58P | 0.975 |
| 16:75669408:C:A | R54S | 0.971 |
| 16:75669408:C:G | R54S | 0.971 |
| 16:75661221:A:G | L79P | 0.967 |
| 16:75661245:C:G | W71S | 0.966 |
| 16:75661243:A:C | F72V | 0.965 |
| 16:75669417:G:C | F51L | 0.964 |
| 16:75669417:G:T | F51L | 0.964 |
dbSNP variants (sampled 300 via entrez): RS1000024016 (16:75666114 A>C), RS1000134974 (16:75660708 C>G,T), RS1000389850 (16:75659909 G>A,T), RS1000394111 (16:75660753 T>A,C), RS1000438257 (16:75670471 G>T), RS1000522772 (16:75674642 A>C), RS1000607965 (16:75674383 A>G), RS1000816075 (16:75669681 C>G), RS1000885592 (16:75664580 G>A), RS1000968613 (16:75664467 A>C), RS1001044982 (16:75669415 G>A), RS1001145059 (16:75664387 A>G), RS1001200153 (16:75666446 T>A,C), RS1001357469 (16:75661375 C>T), RS1001415586 (16:75669124 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.